No

Corticosteroid, Topical

Inflammation of corticosteroid-responsive dermatoses (medium potency topical corticosteroid)

C

Known hypersensitivity to clocortolone; viral, fungal, or tubercular skin lesions

Adrenal suppression can occur if used for >14 days

1% to 10%:

Dermatologic: Itching, erythema

Local: Burning, dryness, irritation, papular rashes

<1%: Hypertrichosis, acneiform eruptions, maceration of skin, skin atrophy, striae, hypopigmentation, perioral dermatitis, miliaria

No data reported

Stimulates the synthesis of enzymes needed to decrease inflammation, suppress mitotic activity, and cause vasoconstriction

Absorption: Percutaneous absorption is variable and dependent upon many factors including vehicle used, integrity of epidermis, dose, and use of occlusive dressings;

Distribution: Small amounts enter systemic circulation mostly throughout skin

Metabolism: Remains to be defined (largely in liver)

Elimination: In urine and bile

Adults: Apply sparingly and gently; rub into affected area from 1-4 times/day. Therapy should be discontinued when control is achieved; if no improvement is seen, reassessment of diagnosis may be necessary.

No information available to require special precautions

No effects or complications reported

A thin film of cream or ointment is effective; do not overuse; do not use tight-fitting diapers or plastic pants on children being treated in the diaper area; use only as prescribed, and for no longer than the period prescribed; apply sparingly in light film; rub in lightly; avoid contact with eyes; notify physician if condition being treated persists or worsens

For external use only; do not use on open wounds; apply sparingly to occlusive dressings; should not be used in the presence of open or weeping lesions

Cream, as pivalate: 0.1% (15 g, 45 g)